Biotech’s richest startup, Moderna Therapeutics, is losing its top attorney amid a legal fight that threatens its future profitability. His exit comes just two months after one of Moderna’s key partners aligned with its legal rival, casting further doubt on the company’s odds of prevailing in court.
The new developments — coming atop a string of departures of top executives — underline swirling questions over whether Moderna can follow through on its oft-repeated promise to upend the drug industry.
About the Author Reprints
